Kane Biotech Inc.
KNBIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,828 | $11,365 | $9,807 | $17,607 |
| - Cash | $359 | $749 | $1,105 | $1,153 |
| + Debt | $2,175 | $9,259 | $6,857 | $4,715 |
| Enterprise Value | $16,644 | $19,875 | $15,559 | $21,169 |
| Revenue | $2,081 | $149 | $2,668 | $1,608 |
| % Growth | 1,296.8% | -94.4% | 66% | – |
| Gross Profit | $872 | $109 | $1,413 | $568 |
| % Margin | 41.9% | 73.5% | 53% | 35.4% |
| EBITDA | -$3,707 | -$3,234 | -$2,947 | -$4,246 |
| % Margin | -178.2% | -2,171% | -110.5% | -264.1% |
| Net Income | $6,098 | -$5,034 | -$3,890 | -$4,605 |
| % Margin | 293% | -3,379% | -145.8% | -286.4% |
| EPS Diluted | -0.024 | -0.036 | -0.033 | -0.041 |
| % Growth | 34.3% | -7.8% | 18.6% | – |
| Operating Cash Flow | -$4,111 | -$3,222 | -$3,043 | -$2,289 |
| Capital Expenditures | -$90 | -$9 | -$88 | -$354 |
| Free Cash Flow | -$4,201 | -$3,231 | -$3,131 | -$2,643 |